Post-Treatment Plasma EBV-DNA Positivity Predicts Early Relapse and Poor Prognosis for Patients With Extranodal NK/T Cell Lymphoma in the Era of Asparaginase
Oncotarget - United States
doi 10.18632/oncotarget.4505
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 3, 2015
Authors
Publisher
Impact Journals, LLC